United States · Business news
112 stories · latest 05 Oct 2026 · clear filter
These are the first US deals to launch in the fourth quarter, and both are small, clinical-stage companies with no product revenue: the money funds trials. TRex Bio's lead programme has topline data due in mid-2027 and…
Fewer and smaller deals cut equity underwriting fees for investment banks and delay exits for private-equity and venture backers. Renaissance tied the slowdown to concerns about AI spending, a 19-year high in bond…
The pulled deal followed Holtec Nuclear's suspended and later withdrawn IPO and Bamboo Insurance's delayed listing, a sign that a spike in bond yields and fears of more Federal Reserve rate hikes had narrowed the…
The listing gives US funds direct access to one of the largest DRAM and flash memory makers, whose chips go into AI servers, and the report said the listing is aimed at narrowing its valuation gap with US-listed rival…
The deal raised more than all US IPOs of the previous two calendar years combined, according to Renaissance Capital, and created one of the largest listed US companies overnight. Index funds and benchmarked managers…
It was the first very large US tech IPO of 2026 and a direct test of investor appetite for alternatives to Nvidia in AI inference chips. The reception is a reference point for listed AI-hardware peers and for AI and…